Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 523

1.

De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy.

Andrejeva G, Gowan S, Lin G, Wong Te Fong AL, Shamsaei E, Parkes HG, Mui J, Raynaud FI, Asad Y, Vizcay-Barrena G, Nikitorowicz-Buniak J, Valenti M, Howell L, Fleck RA, Martin LA, Kirkin V, Leach MO, Chung YL.

Autophagy. 2019 Sep 13:1-17. doi: 10.1080/15548627.2019.1659608. [Epub ahead of print]

PMID:
31517566
2.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R.

PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.

3.

Interim restoration technique for gingival displacement with a feather-edge preparation design and digital scan.

Schmitz JH, Valenti M.

J Prosthet Dent. 2019 Jul 30. pii: S0022-3913(19)30341-5. doi: 10.1016/j.prosdent.2019.04.020. [Epub ahead of print]

PMID:
31375275
4.

Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.

Mercadante S, Masedu F, Valenti M, Aielli F.

Oral Oncol. 2019 Aug;95:87-90. doi: 10.1016/j.oraloncology.2019.06.006. Epub 2019 Jun 11.

PMID:
31345399
5.

Physical Exercise Modulates miR-21-5p, miR-129-5p, miR-378-5p, and miR-188-5p Expression in Progenitor Cells Promoting Osteogenesis.

Valenti MT, Deiana M, Cheri S, Dotta M, Zamboni F, Gabbiani D, Schena F, Dalle Carbonare L, Mottes M.

Cells. 2019 Jul 19;8(7). pii: E742. doi: 10.3390/cells8070742.

6.

Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review.

Giménez A, Pacchiarotti I, Gil J, Murru A, Gomes SP, Pinzón JE, Anmella G, Gómez-Ramiro M, Verdolini N, Valentí M, Goikolea JM, Vieta E.

Psychiatr Pol. 2019 Apr 30;53(2):223-244. doi: 10.12740/PP/105906. Epub 2019 Apr 30. English, Polish.

8.

Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people.

Del Ser T, Zea MA, Valentí M, Olazarán J, López-Álvarez J, Rebollo-Vázquez A, Ávila-Villanueva M, Frades B, Medina M, Fernández-Blázquez MA.

J Psychopharmacol. 2019 Aug;33(8):965-974. doi: 10.1177/0269881119857206. Epub 2019 Jun 26.

PMID:
31241413
9.

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study.

Guadagni S, Fiorentini G, Mambrini A, Masedu F, Valenti M, Mackay AR, Sarti D, Ricevuto E, Clementi M, Catarci M, Lazzarin G, Bruera G.

Oncotarget. 2019 Jun 11;10(39):1-13. doi: 10.18632/oncotarget.26972. eCollection 2019 Jun 11.

10.

Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae.

Coronas-Serna JM, Valenti M, Del Val E, Fernández-Acero T, Rodríguez-Escudero I, Mingo J, Luna S, Torices L, Pulido R, Molina M, Cid VJ.

Int Microbiol. 2019 Jun 19. doi: 10.1007/s10123-019-00082-4. [Epub ahead of print] Review.

PMID:
31218536
11.

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Jul;38(28):5746. doi: 10.1038/s41388-019-0835-1.

PMID:
31147600
12.

Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.

Cecconi D, Brandi J, Manfredi M, Serena M, Carbonare LD, Deiana M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Avanzi F, Antoniazzi F, Marengo E, Tiso N, Mottes M, Zipeto D, Valenti MT.

Sci Rep. 2019 May 29;9(1):8052. doi: 10.1038/s41598-019-44552-1.

13.

Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.

Dalla Grana E, Rigo F, Lanzafame M, Lattuada E, Suardi S, Mottes M, Valenti MT, Dalle Carbonare L.

Front Endocrinol (Lausanne). 2019 May 14;10:302. doi: 10.3389/fendo.2019.00302. eCollection 2019.

14.

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.

Carvalho D, Taylor KR, Olaciregui NG, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM, Jones C.

Commun Biol. 2019 May 9;2:156. doi: 10.1038/s42003-019-0420-8. eCollection 2019.

15.

Electronic Effects Determine the Selectivity of Planar Au-Cu Bimetallic Thin Films for Electrochemical CO2 Reduction.

Liu K, Ma M, Wu L, Valenti M, Cardenas-Morcoso D, Hofmann JP, Bisquert J, Gimenez S, Smith WA.

ACS Appl Mater Interfaces. 2019 May 8;11(18):16546-16555. doi: 10.1021/acsami.9b01553. Epub 2019 Apr 29.

16.

Alteration of myocardial GRK2 produces a global metabolic phenotype.

Woodall BP, Gresham KS, Woodall MA, Valenti MC, Cannavo A, Pfleger J, Chuprun JK, Drosatos K, Koch WJ.

JCI Insight. 2019 Apr 4;5. pii: 123848. doi: 10.1172/jci.insight.123848.

17.

Effects of Oral Anticoagulant Therapy on Gene Expression in Crosstalk between Osteogenic Progenitor Cells and Endothelial Cells.

Dalle Carbonare L, Mottes M, Brunelli A, Deiana M, Cheri S, Suardi S, Valenti MT.

J Clin Med. 2019 Mar 8;8(3). pii: E329. doi: 10.3390/jcm8030329.

18.

Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.

Mercadante S, Adile C, Masedu F, Valenti M, Aielli F.

J Pain Symptom Manage. 2019 May;57(5):966-970. doi: 10.1016/j.jpainsymman.2019.02.014. Epub 2019 Feb 26.

PMID:
30822530
19.

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.

Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E.

Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470. doi: 10.1016/j.euroneuro.2019.02.003. Epub 2019 Feb 12. Review.

PMID:
30770235
20.

Maximizing New Technologies to Treat Depression.

Decker V, Valenti M, Montoya V, Sikorskii A, Given CW, Given BA.

Issues Ment Health Nurs. 2019 Mar;40(3):200-207. doi: 10.1080/01612840.2018.1527422. Epub 2019 Jan 8.

PMID:
30620622
21.

Diketopyrrolopyrrole Bis-Phosphonate Conjugate: A New Fluorescent Probe for In Vitro Bone Imaging.

Chiminazzo A, Borsato G, Favero A, Fabbro C, McKenna CE, Dalle Carbonare LG, Valenti MT, Fabris F, Scarso A.

Chemistry. 2019 Mar 7;25(14):3617-3626. doi: 10.1002/chem.201805436. Epub 2019 Feb 12.

PMID:
30600841
22.

Vitamin D Daily versus Monthly Administration: Bone Turnover and Adipose Tissue Influences.

Dalle Carbonare L, Valenti MT, Del Forno F, Piacentini G, Pietrobelli A.

Nutrients. 2018 Dec 6;10(12). pii: E1934. doi: 10.3390/nu10121934.

23.

New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.

Deiana M, Dalle Carbonare L, Serena M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Manfredi M, Marengo E, Brandi J, Cecconi D, Mori A, Mina MM, Antoniazzi F, Mottes M, Tiso N, Malerba G, Zipeto D, Valenti MT.

Cells. 2018 Nov 20;7(11). pii: E220. doi: 10.3390/cells7110220.

24.

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Mar;38(10):1717-1733. doi: 10.1038/s41388-018-0554-z. Epub 2018 Oct 23. Erratum in: Oncogene. 2019 May 30;:.

25.

Preliminary analysis of effects of the 2006 Turin Winter Olympic Games on air quality.

Senese A, Valenti M, Senese V.

PLoS One. 2018 Oct 18;13(10):e0205975. doi: 10.1371/journal.pone.0205975. eCollection 2018.

26.

Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4 H-1,2,4-triazol-3-yl)phenyl)-6-methyl- N8-neopentylpyrido[3,4- d]pyrimidine-2,8-diamine (BOS172722).

Woodward HL, Innocenti P, Cheung KJ, Hayes A, Roberts J, Henley AT, Faisal A, Mak GW, Box G, Westwood IM, Cronin N, Carter M, Valenti M, De Haven Brandon A, O'Fee L, Saville H, Schmitt J, Burke R, Broccatelli F, van Montfort RLM, Raynaud FI, Eccles SA, Linardopoulos S, Blagg J, Hoelder S.

J Med Chem. 2018 Sep 27;61(18):8226-8240. doi: 10.1021/acs.jmedchem.8b00690. Epub 2018 Sep 10.

27.

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Banerji U, Sain N, Sharp SY, Valenti M, Asad Y, Ruddle R, Raynaud F, Walton M, Eccles SA, Judson I, Jackman AL, Workman P.

Cancer Chemother Pharmacol. 2018 Nov;82(5):911-912. doi: 10.1007/s00280-018-3674-9.

PMID:
30173339
28.

Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.

Mercadante S, Marinangeli F, Masedu F, Valenti M, Russo D, Ursini L, Massici A, Aielli F.

J Pain Symptom Manage. 2018 Dec;56(6):902-907. doi: 10.1016/j.jpainsymman.2018.08.018. Epub 2018 Aug 31.

PMID:
30172864
29.

Cine 4DCT imaging artifacts: Quantification and correlations with scanning parameters and target kinetics.

Valenti M, Campanelli A, Parisotto M, Maggi S.

Phys Med. 2018 Aug;52:133-142. doi: 10.1016/j.ejmp.2018.07.006. Epub 2018 Jul 30.

PMID:
30139602
30.

Ectopic expression of the osteogenic master gene RUNX2 in melanoma.

Valenti MT, Dalle Carbonare L, Mottes M.

World J Stem Cells. 2018 Jul 26;10(7):78-81. doi: 10.4252/wjsc.v10.i7.78.

31.

Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder.

Bonnín CM, Martínez-Arán A, Reinares M, Valentí M, Solé B, Jiménez E, Montejo L, Vieta E, Rosa AR.

J Affect Disord. 2018 Nov;240:57-62. doi: 10.1016/j.jad.2018.07.045. Epub 2018 Jul 17.

PMID:
30053684
32.

Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.

Mercadante S, Adile C, Lanzetta G, Mystakidou K, Maltoni M, Guilherme Soares L, De Santis S, Ferrera P, Valenti M, Rosati M, Rossi R, Cortegiani A, Masedu F, Marinangeli F, Aielli F.

Oncologist. 2019 Feb;24(2):239-246. doi: 10.1634/theoncologist.2017-0668. Epub 2018 May 16.

PMID:
29769382
33.

Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study.

Goikolea JM, Dima D, Landín-Romero R, Torres I, DelVecchio G, Valentí M, Amann BL, Bonnín CM, McKenna PJ, Pomarol-Clotet E, Frangou S, Vieta E.

Schizophr Bull. 2019 Mar 7;45(2):464-473. doi: 10.1093/schbul/sby047.

PMID:
29672741
34.

Diet: the keystone of autism spectrum disorder?

Peretti S, Mariano M, Mazzocchetti C, Mazza M, Pino MC, Verrotti Di Pianella A, Valenti M.

Nutr Neurosci. 2018 Apr 19:1-15. doi: 10.1080/1028415X.2018.1464819. [Epub ahead of print]

PMID:
29669486
35.

An integrated approach identifies new oncotargets in melanoma.

Cecconi D, Carbonare LD, Mori A, Cheri S, Deiana M, Brandi J, Degaetano V, Masiero V, Innamorati G, Mottes M, Malerba G, Valenti MT.

Oncotarget. 2017 Dec 15;9(14):11489-11502. doi: 10.18632/oncotarget.23727. eCollection 2018 Feb 20.

36.

The curious case of Gαs gain-of-function in neoplasia.

Innamorati G, Wilkie TM, Kantheti HS, Valenti MT, Dalle Carbonare L, Giacomello L, Parenti M, Melisi D, Bassi C.

BMC Cancer. 2018 Mar 15;18(1):293. doi: 10.1186/s12885-018-4133-z.

37.

Can disc diffusion susceptibility tests assess the antimicrobial activity of engineered nanoparticles?

Kourmouli A, Valenti M, van Rijn E, Beaumont HJE, Kalantzi OI, Schmidt-Ott A, Biskos G.

J Nanopart Res. 2018;20(3):62. doi: 10.1007/s11051-018-4152-3. Epub 2018 Mar 2.

38.

Predictors of Underrepresented Nursing Students' School Satisfaction, Success, and Future Education Intent.

Williams LB, Bourgault AB, Valenti M, Howie M, Mathur S.

J Nurs Educ. 2018 Mar 1;57(3):142-149. doi: 10.3928/01484834-20180221-03.

PMID:
29505071
39.

The role of sleep in aesthetic perception and empathy: A mediation analysis.

Peretti S, Tempesta D, Socci V, Pino MC, Mazza M, Valenti M, De Gennaro L, Di Dio C, Marchetti A, Ferrara M.

J Sleep Res. 2019 Jun;28(3):e12664. doi: 10.1111/jsr.12664. Epub 2018 Feb 6.

PMID:
29405533
40.

Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review).

Valenti MT, Dalle Carbonare L, Mottes M.

Int J Mol Med. 2018 May;41(5):2441-2449. doi: 10.3892/ijmm.2018.3452. Epub 2018 Feb 1. Review.

PMID:
29393379
41.

Hot Carrier Generation and Extraction of Plasmonic Alloy Nanoparticles.

Valenti M, Venugopal A, Tordera D, Jonsson MP, Biskos G, Schmidt-Ott A, Smith WA.

ACS Photonics. 2017 May 17;4(5):1146-1152. doi: 10.1021/acsphotonics.6b01048. Epub 2017 Mar 6.

42.

Runx2 overexpression compromises bone quality in acromegalic patients.

Valenti MT, Mottes M, Cheri S, Deiana M, Micheletti V, Cosaro E, Davì MV, Francia G, Dalle Carbonare L.

Endocr Relat Cancer. 2018 Mar;25(3):269-277. doi: 10.1530/ERC-17-0523. Epub 2018 Jan 2.

PMID:
29295822
43.

Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder.

Bonnín CM, Yatham LN, Michalak EE, Martínez-Arán A, Dhanoa T, Torres I, Santos-Pascual C, Valls E, Carvalho AF, Sánchez-Moreno J, Valentí M, Grande I, Hidalgo-Mazzei D, Vieta E, Reinares M.

J Affect Disord. 2018 Mar 1;228:153-159. doi: 10.1016/j.jad.2017.12.006. Epub 2017 Dec 6.

PMID:
29248821
44.

Clodronate as a Therapeutic Strategy against Osteoarthritis.

Valenti MT, Mottes M, Biotti A, Perduca M, Pisani A, Bovi M, Deiana M, Cheri S, Dalle Carbonare L.

Int J Mol Sci. 2017 Dec 13;18(12). pii: E2696. doi: 10.3390/ijms18122696.

45.

Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Davì MV.

Pituitary. 2018 Feb;21(1):56-64. doi: 10.1007/s11102-017-0847-1.

PMID:
29214508
46.

[Bone biopsy in the Chronic Kidney Disease (CKD)].

Dalle Carbonare L, Valenti MT.

G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Review. Italian.

PMID:
29207224
47.

The use of choline in association with the Bangerter filters for the treatment of amblyopia.

Sabetti L, Masedu F, Tresca C, Bianchi F, Valenti M.

Int J Ophthalmol. 2017 Nov 18;10(11):1777-1778. doi: 10.18240/ijo.2017.11.22. eCollection 2017.

48.

Effects of nutraceuticals on sexual satisfaction and lower urinary tract symptoms in a cohort of young-old men.

Perri A, Ilacqua A, Valenti M, Aversa A.

Phytother Res. 2018 Feb;32(2):284-289. doi: 10.1002/ptr.5971. Epub 2017 Nov 23.

PMID:
29168235
49.

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?

Guadagni S, Fiorentini G, Clementi M, Palumbo G, Palumbo P, Chiominto A, Baldoni S, Masedu F, Valenti M, Tommaso AD, Fabi B, Aliberti C, Sarti D, Guadagni V, Pellegrini C.

Int J Mol Sci. 2017 Nov 9;18(11). pii: E2382. doi: 10.3390/ijms18112382.

50.

Can half-marathon affect overall health? The yin-yang of sport.

Dalle Carbonare L, Manfredi M, Caviglia G, Conte E, Robotti E, Marengo E, Cheri S, Zamboni F, Gabbiani D, Deiana M, Cecconi D, Schena F, Mottes M, Valenti MT.

J Proteomics. 2018 Jan 6;170:80-87. doi: 10.1016/j.jprot.2017.09.004. Epub 2017 Sep 6.

PMID:
28887210

Supplemental Content

Loading ...
Support Center